Scholars Central

Conference abstractPublished 22 Jun 2015

Prostatic exosomal protein (PSEP) ELISA method for detecting chronic prostatitis

Authors: Yan Zeng, Ze Qian, Jiao Zhang, Yanhua Chen, Zhenxing Liu, Jun Xu, Hua Song, Chengjin Hu, Qun Lu

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

There is increasing evidence that men with prostate cancer are associated with prostatitis and/or benign prostatic hyperplasia. Therefore, early and reliable diagnosis and treatment of prostatitis may reduce or even prevent prostate cancer progression. Chronic prostatitis/Chronic pelvic pain syndrome (CP/CPPS) is a multifactorial medical condition, which affects adult males of all ages and demographics. Recent studies have shown that the prevalence of prostatitis is approximately 2-10% among unselected men in North America, Europe and Asia. Traditionally, diagnoses have included clinical symptoms and signs, a routine urine test, or culture as well as the expressed prostatic secretion (EPS) during rectal exams. But there is no standard diagnostic test for nonbacterial CP/CPPS, which makes effective treatments more challenging. As a result, it is quite important to equip urologists with a useful tool for the diagnosis of CP/CPPS. We isolated PSEP from the urine of CP/CPPS patients and used it as the immunogen to generate mouse monoclonal antibodies. Purified antibodies were used to establish an indirect ELISA method and study a total of 140 urine samples of CP/CPPS and 60 normal control urine samples. The amount of PESP in the urine of CP/CPPS patients (3.013±2.199 ng/ml) was significantly higher than that in the group of normal control urine samples (0.734±0.574ng/ml). There were statistically significant differences between the two groups (Z=10.74, P<0.05). The cut-off value obtained in this study was about 1.2 ng/ml. The sensitivity was 88.57% in the 140 urine samples of CP/CPPS patients and the specificity was 90% in the normal urines. Comparing the results of PSEP test kits to the traditional clinical standard, Kappa was 0.75 (95% CI=0.652 to 0.848) with P<0.01. In this study, PSEP ELISA kit showed high sensitivity and specificity. Additionally, its detection outcomes were highly consistent with those of the clinical observation. Thus we suggest that PSEP ELISA application can support reliable CP/CPPS diagnosis.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Cancer Science & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCancer Science & Therapy
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Yan Zeng”
  • BylineArticles whose byline prints “Ze Qian”
  • BylineArticles whose byline prints “Jiao Zhang”
  • BylineArticles whose byline prints “Yanhua Chen”
  • BylineArticles whose byline prints “Zhenxing Liu”
  • BylineArticles whose byline prints “Jun Xu”
  • BylineArticles whose byline prints “Hua Song”
  • BylineArticles whose byline prints “Chengjin Hu”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels